BioCentury | Feb 1, 2016
Company News

Orega Biotech, Innate Pharma deal

...regulatory milestones, plus undisclosed royalties. The companies declined to provide further details or financial terms. Orega Biotech S.A.S....
Items per page:
1 - 1 of 1
BioCentury | Feb 1, 2016
Company News

Orega Biotech, Innate Pharma deal

...regulatory milestones, plus undisclosed royalties. The companies declined to provide further details or financial terms. Orega Biotech S.A.S....
Items per page:
1 - 1 of 1